[144] SEMPRA SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Sempra (symbol: SREA) shows a proposed sale of 28,864 shares of common stock through Oppenheimer & Co., with an aggregate market value of $2,422,844.16 and an approximate sale date of 09/15/2025. The filing reports that all shares to be sold were acquired primarily through vesting of restricted stock units and reinvested dividends under Sempra's Long-Term Incentive Plan, with acquisition dates ranging from 01/03/2022 through 02/19/2025. The filing lists 652,472,426 shares outstanding, and discloses that there were no securities sold by the filer in the past three months.
Positive
- Full acquisition traceability: All shares to be sold are documented as vested restricted stock units or reinvested dividends under the company's Long-Term Incentive Plan
- Named broker and market value disclosed: Sale to be executed through Oppenheimer with an aggregate market value of $2,422,844.16
- No recent disposals: Filers report "Nothing to Report" for securities sold in the past three months
Negative
- None.
Insights
TL;DR: Routine insider sale of vested RSUs representing a small fraction of outstanding shares; appears procedural rather than a material company event.
The Form 144 documents a planned sale of 28,864 shares with an aggregate market value of $2,422,844.16 to be executed via Oppenheimer on or about 09/15/2025. The securities were acquired through vesting of restricted stock units and reinvested dividends from 2022 through 2025, consistent with compensation-related dispositions. There were no reported sales by the filer in the prior three months, and the shares to be sold represent a negligible percentage of the 652,472,426 shares outstanding. From an equity-impact perspective, this filing is procedural and unlikely to move valuation metrics materially.
TL;DR: Disclosure aligns with Rule 144 requirements; shows transparent reporting of compensation-origin shares and planned broker-assisted sale.
The notice provides the required chain-of-acquisition detail: multiple vesting events and reinvested dividends tied to Sempra's Long-Term Incentive Plan, listing dates and unit counts that sum to the 28,864 shares to be sold. The use of a named broker and the explicit representation that the filer is unaware of undisclosed material adverse information reflect compliance-focused disclosures. This filing documents an individual disposition of compensation-related equity rather than any governance action by the issuer.